Prestige CEO Tightens Focus On OTCs, Considers Divesting Personal Care
This article was originally published in The Rose Sheet
Executive Summary
Prestige Brands Holdings may look to divest its entire personal care segment to sharpen its focus on its OTC drug and household products, new CEO Matt Mannelly told analysts in a Nov. 5 earnings call